BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300 AND Treatment
114 results:

  • 1. Near infrared-responsive quinacrine-gold hybrid nanoparticles deregulate HSP-70/p300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells.
    Dash SR; Das C; Das B; Jena AB; Paul S; Sinha S; Tripathy J; Kundu CN
    Nanomedicine (Lond); 2024 Mar; 19(7):581-596. PubMed ID: 38293827
    [No Abstract]    [Full Text] [Related]  

  • 2. Novel berberine derivatives as p300 histone acetyltransferase inhibitors in combination treatment for breast cancer.
    Lai R; Lin Z; Yang C; Hai L; Yang Z; Guo L; Nie R; Wu Y
    Eur J Med Chem; 2024 Feb; 266():116116. PubMed ID: 38215590
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Vitamin D inhibits tamoxifen-induced non-alcoholic fatty liver disease through a nonclassical estrogen receptor/liver X receptor pathway.
    Wu M; Wang J; Zhou W; Wang M; Hu C; Zhou M; Jiao K; Li Z
    Chem Biol Interact; 2024 Feb; 389():110865. PubMed ID: 38191086
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Roles and signaling pathways of CITED1 in tumors: overview and novel insights.
    Chen W; Jiang J; Gao J; Wang G; Wang R; Lv J; Ben J
    J Int Med Res; 2024 Jan; 52(1):3000605231220890. PubMed ID: 38190845
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. I-CBP112 declines overexpression of ATP-binding cassette transporters and sensitized drug-resistant MDA-MB-231 and A549 cell lines to chemotherapy drugs.
    Strachowska M; Gronkowska K; Sobczak M; Grodzicka M; Michlewska S; Kołacz K; Sarkar T; Korszun J; Ionov M; Robaszkiewicz A
    Biomed Pharmacother; 2023 Dec; 168():115798. PubMed ID: 37913733
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Combination Curcuma longa and Phyllanthus niruri Extract Potentiate Antiproliferative in Triple Negative breast cancer MDAMB-231 Cells.
    Hermansyah D; Anggia Paramita D; Paramita DA; Amalina ND
    Asian Pac J Cancer Prev; 2023 May; 24(5):1495-1505. PubMed ID: 37247268
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The activation of ep300 by F11R leads to EMT and acts as a prognostic factor in triple-negative breast cancers.
    Li CH; Fang CY; Chan MH; Lu PJ; Ger LP; Chu JS; Chang YC; Chen CL; Hsiao M
    J Pathol Clin Res; 2023 May; 9(3):165-181. PubMed ID: 36782375
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. breast cancer molecular diagnostics in Rwanda: a cost-minimization study of immunohistochemistry versus a novel GeneXpert
    Erfani P; Gaga E; Hakizimana E; Kayitare E; Mugunga JC; Shyirambere C; Milner DA; Shulman LN; Ruhangaza D; Fadelu T
    Bull World Health Organ; 2023 Jan; 101(1):10-19. PubMed ID: 36593782
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Radiation Therapy Expenditures Through the First 8 Performance Periods of the Oncology Care Model at a Statewide Multispecialty Health System.
    De B; Andres G; Bates C; Staren E; Kutscher E; Brooks DJ; Thaker GH; Buscema J; Gin R; Thaker N
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(3):491-499. PubMed ID: 36427644
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Estrone, the major postmenopausal estrogen, binds ERa to induce SNAI2, epithelial-to-mesenchymal transition, and ER+ breast cancer metastasis.
    Qureshi R; Picon-Ruiz M; Sho M; Van Booven D; Nunes de Paiva V; Diaz-Ruano AB; Ince TA; Slingerland J
    Cell Rep; 2022 Nov; 41(7):111672. PubMed ID: 36384125
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Skp2-mediated Zeb1 expression facilitates cancer migration by a ubiquitination-independent pathway.
    Wang HC; Luo CW; Chen TY; Chen YZ; Fang SY; Lai CY; Hung WC; Wu CC; Chen LT; Liu YC; Pan MR
    Life Sci; 2022 Dec; 311(Pt A):121135. PubMed ID: 36349605
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. EBF1 promotes triple-negative breast cancer progression by surveillance of the HIF1α pathway.
    Qiu Z; Guo W; Dong B; Wang Y; Deng P; Wang C; Liu J; Zhang Q; Grosschedl R; Yu Z; Deng J; Wu Y
    Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2119518119. PubMed ID: 35867755
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Analysis of estrogen-regulated enhancer RNAs identifies a functional motif required for enhancer assembly and gene expression.
    Hou TY; Kraus WL
    Cell Rep; 2022 Jun; 39(11):110944. PubMed ID: 35705040
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study.
    Pinato DJ; Aguilar-Company J; Ferrante D; Hanbury G; Bower M; Salazar R; Mirallas O; Sureda A; Plaja A; Cucurull M; Mesia R; Townsend S; Jackson A; Dalla Pria A; Newsom-Davis T; Handford J; Sita-Lumsden A; Apthorp E; Vincenzi B; Bertuzzi A; Brunet J; Lambertini M; Maluquer C; Pedrazzoli P; Biello F; Sinclair A; Bawany S; Khalique S; Rossi S; Rogers L; Murphy C; Belessiotis K; Carmona-García MC; Sharkey R; García-Illescas D; Rizzo G; Perachino M; Saoudi-Gonzalez N; Doonga K; Fox L; Roldán E; Gaidano G; Ruiz-Camps I; Bruna R; Patriarca A; Martinez-Vila C; Cantini L; Zambelli A; Giusti R; Mazzoni F; Caliman E; Santoro A; Grosso F; Parisi A; Queirolo P; Aujayeb A; Rimassa L; Prat A; Tucci M; Libertini M; Grisanti S; Mukherjee U; Diamantis N; Fusco V; Generali D; Provenzano S; Gennari A; Tabernero J; Cortellini A;
    Lancet Oncol; 2022 Jul; 23(7):865-875. PubMed ID: 35660139
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Proton pump inhibitors may reduce the efficacy of ribociclib and palbociclib in metastatic breast cancer patients based on an observational study.
    Eser K; Önder AH; Sezer E; Çil T; İnal A; Öztürk B; Erçolak V; Duman BB; Çelik H; Köşeci T; Kesen O
    BMC Cancer; 2022 May; 22(1):516. PubMed ID: 35525929
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. SETD5 Regulates Glycolysis in breast cancer Stem-Like Cells and Fuels Tumor Growth.
    Yang Z; Zhang C; Liu X; Che N; Feng Y; Xuan Y
    Am J Pathol; 2022 Apr; 192(4):712-721. PubMed ID: 35063407
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. ERα promotes transcription of tumor suppressor gene
    Wang B; Shen Y; Liu T; Tan L
    J Zhejiang Univ Sci B; 2021 Dec; 22(12):1034-1044. PubMed ID: 34904415
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prognostic Model for De Novo and Recurrent Metastatic breast cancer.
    Barcenas CH; Song J; Murthy RK; Raghavendra AS; Li Y; Hsu L; Carlson RW; Tripathy D; Hortobagyi GN
    JCO Clin Cancer Inform; 2021 Aug; 5():789-804. PubMed ID: 34351787
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Nuclear Aurora-A kinase-induced hypoxia signaling drives early dissemination and metastasis in breast cancer: implications for detection of metastatic tumors.
    Whately KM; Voronkova MA; Maskey A; Gandhi J; Loskutov J; Choi H; Yanardag S; Chen D; Wen S; Margaryan NV; Smolkin MB; Purazo ML; Hu G; Pugacheva EN
    Oncogene; 2021 Sep; 40(37):5651-5664. PubMed ID: 34326467
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Carboxyl group-modified α-lactalbumin induces TNF-α-mediated apoptosis in leukemia and breast cancer cells through the NOX4/p38 MAPK/PP2A axis.
    Chiou JT; Shi YJ; Lee YC; Wang LJ; Chen YJ; Chang LS
    Int J Biol Macromol; 2021 Sep; 187():513-527. PubMed ID: 34310992
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.